Skip to main content
Simon Robson, MD, Gastroenterology, Boston, MA, Beth Israel Deaconess Medical Center

SimonC.RobsonMDPhD FAASLD(He/Him)

Gastroenterology Boston, MA

Gastrointestinal Cancer, Hepatology & Liver Transplantation, Inflammatory Bowel Disease

Professor, Medicine and Anesthesiology, Vice Chair Research, Beth Israel Deaconess Medical Center, Harvard Medical School

Dr. Robson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Robson's full profile

Already have an account?

  • Office

    330 Brookline Avenue
    Beth Israel Deaconess Medical Center
    Boston, MA 02215
    Phone+1 617-632-1070
    Fax+1 617-632-1861
  • Is this information wrong?

Summary

  • Physician Scientist with expertise in Hepatology and Inflammation.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, Transplantation, 1993 - 1996
  • University of Cape Town
    University of Cape TownPhD, 1989
  • Kings College Hospital
    Kings College HospitalMRCP, 1982 - 1983
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1978

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1997 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Plenary and Keynote Lectures PURINES2018, PURINES2022, 2018, 2022
  • John Hedley-Whyte Lectureship Anesthesia, BIDMC, 2021
  • Subcommittee of Professors Harvard Medical School, 2018, 2020-2021
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Adenosine generation by CD39 and CD73 on T regulatory cells mediates immune suppression  
    Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC, The Journal of Experimental Medicine, 1/1/2007
  • Purinergic Signaling during Inflammation  
    Eltzschig HK, Sitkovsky MV, Robson SC, N Engl J Med, 12/13/2012
  • Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury  
    Nowak-Machen M, Schmelzle M, Hanidziar D, Junger W, Exley M, Otterbein L, Wu Y, Csizmadia E, Doherty G, Sitkovsky M, Robson SC, Am J Respir Cell Mol Biol, 5/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Lower Risk of Cardiac Rupture in CD39 Null Mice Post-myocardial Infarction
    Ogawa M, Ogawa N, Nakayama M, Csizmadia E, Enjyoji K, Kohzuki M, Robson SC, J. American College of Cardiology, 1/1/2005
  • Adenosine A1 and A2A Receptors. CD39/CD73KO Influence Granulomatousresponses to BCG
    Kara FM, Montesinos MC, Mor A, Robson SC, Thompson L, Cronstein BN, 8th International Symposium on Adenosine and Adenine Nucleotides, Ferrara, Italy, 5/1/2006
  • Transcription Factor YY1 and the Retinoblastoma Protein Are Downstream Targets of CD39/ENTPD1 Signaling Pathways during Liver Regeneration
    Wu Y, Imai M, Sun X, Csizmadia E, Enjyoji K, Choi C, Robson SC,Usheva A, Hepatology, 1/1/2005
  • Join now to see all

Lectures

  • Vascular Biology of CD39 and Transplantation Topics 
    Department of Gastroenterology, BIDMC - 1/1/2013
  • Vascular Bed-specific Characteristics of Endothelial Cells 
    Department of Gastroenterology, Mount Sinai Hospital, NY - 1/1/2013
  • Purinergic Signaling in the Liver 
    London, UK - 1/1/2013
  • Join now to see all

Other

  • Hepatic Xenotransplantation. Transplant Report 

    1/1/1995
  • Contributions to Reports in Cape Times, Hepatitis B Immunizations and Liver Transplantation 
    Robson
    1/1/1993
  • Audio-mix, and Pathways to Health 
    Radio Today
    1/1/1993
  • Join now to see all

Grant Support

  • T cell genotype/phenotype influence on atherosclerotic cardiovascular disease.NIH2023–2027
  • Targeting ENTPD3 to boost extracellular ATP and inflame tumors.Emerson Collective CRF2021–2023
  • PGC-1α, Purines and the Postmenopausal Heart.NIH NIA2021–2023
  • DAMP-Mediated Innate Immune Failure and Pneumonia .....DoD2016–2022
  • Directed Purinergic Signaling as Immunotherapy in LeukemiaNIH NCI2018–2020
  • Engineering Inhibitory Antibodies To Ectoenzymes For Cancer TreatmentNational Cancer Institute2012
  • Thromboregulatory Barriers To XenotransplantationNational Institute Of Allergy And Infectious Diseases2000–2011
  • Purinergic ThromboregulationNational Heart, Lung, And Blood Institute2009–2010
  • Thromboregulatory Strategies To Prolong Xenograft Survival.National Institute Of Allergy And Infectious Diseases2006–2009
  • Vascular Topography Of Cd39/NtpdasesNational Heart, Lung, And Blood Institute2004–2008
  • Core--Histological SupportNational Heart, Lung, And Blood Institute2004–2008
  • Functional Analysis Of Vascular NtpdasesNational Heart, Lung, And Blood Institute2000–2007
  • Thromboregulatory Strategies To Prolong XenograftsNational Institute Of Allergy And Infectious Diseases2005
  • Vascular Ntpdases And TransplantationNational Heart, Lung, And Blood Institute2001–2004
  • Vascular Ecto Adpases And TransplantationNational Heart, Lung, And Blood Institute1997–2000

Committees

  • Member, SOP HMS 2018 - 2021

Research History

  • Vice Chair Research AnesthesiaDirector of Center for Inflammation Research2019 - Present

Professional Memberships

  • AASLD
    Member

Other Languages

  • Dutch

Hospital Affiliations

Industry Relationships

  • Scientific Founder, ePURINES2018 - Present
  • Scientific Founder, Purinomia2017 - Present